# A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

> **NCT04535752** · PHASE1 · COMPLETED · sponsor: **Annexon, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Safety and Tolerability in Healthy Volunteers

## Interventions

- **DRUG:** ANX009
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04535752
- **Lead sponsor:** Annexon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-30
- **Primary completion:** 2021-06-26
- **Final completion:** 2021-06-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04535752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04535752, "A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04535752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*